American Conference Institute’s (ACI) Novel Therapeutic Modalities and Gene Therapies

Loeb & Loeb LLP is proud to sponsor the American Conference Institute’s (ACI) Novel Therapeutic Modalities and Gene Therapies taking place from March 21-22, 2023 where partner, Ryan Hagglund will be moderating the panel "Understanding Pre-Commercialization Concerns Relative to the Products of the New BioPharma Revolution" and associate, Dan Liu will be speaking on the panel "mRNA and CRISPR Patent Wars: What Every Life Sciences Business Executive and Counsel Need to Know" on March 21.

From the event website:
mRNA, CRISPR, CAR T – all acronyms for emerging and novel therapeutics that are changing modern medicine as we know it. However, the complexities concerning ownership, funding, and tech strategies for these next generation therapeutic modalities and gene therapies are the greatest barriers to commercialization. ACI has created The National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies to provide you with solutions to some of the greatest challenges impeding market access for these products.

For more information, including how to register, please visit the event website.